Buerger's disease risk factors: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Buerger's disease}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. {{CMG}} ==Overv..." |
Ahmed Younes (talk | contribs) No edit summary |
||
| (9 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Buerger's disease}} | {{Buerger's disease}} | ||
{{CMG}};{{AE}}{{HM}} | |||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of Buerger's disease is [[tobacco smoking]]. Other risk factors include male sex, [[Rickettsial infections|rickettsial infection]], South Asian or Middle Eastern descent, age between 20 - 45 years and a medical history of [[Raynaud's disease]] or [[autoimmune disease]]. | |||
==Risk Factors== | ==Risk Factors== | ||
The most potent risk factor in the development of Buerger's disease is [[tobacco smoking]]. Other risk factors include:<ref name="pmid1772769">{{cite journal |vauthors=Mills JL, Porter JM |title=Buerger's disease (thromboangiitis obliterans) |journal=Ann Vasc Surg |volume=5 |issue=6 |pages=570–2 |date=November 1991 |pmid=1772769 |doi=10.1007/BF02015288 |url=}}</ref><ref name="pmid1598672">{{cite journal |vauthors=Papa M, Bass A, Adar R, Halperin Z, Schneiderman J, Becker CG, Brautbar H, Mozes E |title=Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex |journal=Surgery |volume=111 |issue=5 |pages=527–31 |date=May 1992 |pmid=1598672 |doi= |url=}}</ref><ref name="pmid18172574">{{cite journal |vauthors=Tavakoli H, Rezaii J, Esfandiari K, Salimi J, Rashidi A |title=Buerger's disease: a 10-year experience in Tehran, Iran |journal=Clin. Rheumatol. |volume=27 |issue=3 |pages=369–71 |date=March 2008 |pmid=18172574 |doi=10.1007/s10067-007-0784-x |url=}}</ref> | |||
*Male sex | |||
*[[Rickettsial infections|Rickettsial infection]] | |||
*South Asian or Middle Eastern descent | |||
*Age between 20 - 45 years | |||
*Medical history of [[Raynaud's disease]] or [[autoimmune disease]] | |||
==References== | ==References== | ||
{{ | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | |||
[[Category:Cardiovascular diseases]] | |||
[[Category:Angiology]] | |||
[[Category:Cardiology]] | |||
[[Category:Rheumatology]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 01:29, 30 April 2018
|
Buerger's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Buerger's disease risk factors On the Web |
|
American Roentgen Ray Society Images of Buerger's disease risk factors |
|
Risk calculators and risk factors for Buerger's disease risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
The most potent risk factor in the development of Buerger's disease is tobacco smoking. Other risk factors include male sex, rickettsial infection, South Asian or Middle Eastern descent, age between 20 - 45 years and a medical history of Raynaud's disease or autoimmune disease.
Risk Factors
The most potent risk factor in the development of Buerger's disease is tobacco smoking. Other risk factors include:[1][2][3]
- Male sex
- Rickettsial infection
- South Asian or Middle Eastern descent
- Age between 20 - 45 years
- Medical history of Raynaud's disease or autoimmune disease
References
- ↑ Mills JL, Porter JM (November 1991). "Buerger's disease (thromboangiitis obliterans)". Ann Vasc Surg. 5 (6): 570–2. doi:10.1007/BF02015288. PMID 1772769.
- ↑ Papa M, Bass A, Adar R, Halperin Z, Schneiderman J, Becker CG, Brautbar H, Mozes E (May 1992). "Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex". Surgery. 111 (5): 527–31. PMID 1598672.
- ↑ Tavakoli H, Rezaii J, Esfandiari K, Salimi J, Rashidi A (March 2008). "Buerger's disease: a 10-year experience in Tehran, Iran". Clin. Rheumatol. 27 (3): 369–71. doi:10.1007/s10067-007-0784-x. PMID 18172574.